MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

11 Nov 2021 Evaluate
The sales figure stood at Rs. 350.47 millions for the September 2021 quarter. The mentioned figure indicates a growth of about 28.86% as compared to Rs. 271.98 millions during the year-ago period.Modest increase of 21.56% in the Net Profit was reported from. 113.45 millions to Rs. 137.91  millions.Operating profit surged to 191.60 millions from the corresponding previous quarter of 156.95 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 350.47 271.98 28.86 674.87 428.61 57.46 905.63 851.24 6.39
Other Income 7.15 9.52 -24.89 18.48 18.11 2.04 32.67 17.04 91.73
PBIDT 191.60 156.95 22.08 370.17 231.45 59.94 435.95 335.42 29.97
Interest 1.26 2.84 -55.63 3.22 5.18 -37.84 9.81 9.23 6.28
PBDT 190.34 154.11 23.51 366.95 226.27 62.17 426.14 326.19 30.64
Depreciation 5.77 3.41 69.21 11.18 6.80 64.41 17.33 13.62 27.24
PBT 184.57 150.70 22.48 355.77 219.47 62.10 408.81 312.57 30.79
TAX 46.66 37.25 25.26 88.63 50.30 76.20 107.02 75.82 41.15
Deferred Tax 0.18 0.25 -28.00 -0.24 0.30 -180.00 1.26 -0.54 -333.33
PAT 137.91 113.45 21.56 267.14 169.17 57.91 301.79 236.75 27.47
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 54.67 57.71 -5.26 54.85 54.00 1.57 48.14 39.40 22.17
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..